124 related articles for article (PubMed ID: 26596282)
41. Mechanism of action of amylin in bone.
Tamura T; Miyaura C; Owan I; Suda T
J Cell Physiol; 1992 Oct; 153(1):6-14. PubMed ID: 1325980
[TBL] [Abstract][Full Text] [Related]
42. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts.
Masuyama R; Vriens J; Voets T; Karashima Y; Owsianik G; Vennekens R; Lieben L; Torrekens S; Moermans K; Vanden Bosch A; Bouillon R; Nilius B; Carmeliet G
Cell Metab; 2008 Sep; 8(3):257-65. PubMed ID: 18762026
[TBL] [Abstract][Full Text] [Related]
43. Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.
Herbig ME; Weller K; Krauss U; Beck-Sickinger AG; Merkle HP; Zerbe O
Biophys J; 2005 Dec; 89(6):4056-66. PubMed ID: 16183886
[TBL] [Abstract][Full Text] [Related]
44. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
45. Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption.
Li JP; Kajiya H; Okamoto F; Nakao A; Iwamoto T; Okabe K
Endocrinology; 2007 May; 148(5):2116-25. PubMed ID: 17317768
[TBL] [Abstract][Full Text] [Related]
46. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
47. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1.
Zhang WZ; Yu SF; Zheng LF
Chin Med J (Engl); 1994 May; 107(5):351-4. PubMed ID: 7924575
[TBL] [Abstract][Full Text] [Related]
48. Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures.
Kawaguchi H; Chikazu D; Nakamura K; Kumegawa M; Hakeda Y
J Bone Miner Res; 2000 Mar; 15(3):466-73. PubMed ID: 10750561
[TBL] [Abstract][Full Text] [Related]
49. The effect of human calcitonin on the cytoplasmic spreading of rat osteoclasts.
Chambers TJ; Chambers JC; Symonds J; Darby JA
J Clin Endocrinol Metab; 1986 Nov; 63(5):1080-5. PubMed ID: 3760112
[TBL] [Abstract][Full Text] [Related]
50. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR.
Wagner K; Beck-Sickinger AG; Huster D
Biochemistry; 2004 Oct; 43(39):12459-68. PubMed ID: 15449935
[TBL] [Abstract][Full Text] [Related]
51. Diminished acute response of osteoclasts to calcium load in thyroidectomized patients.
Zikan V; Stepan JJ
Calcif Tissue Int; 2004 Apr; 74(4):377-81. PubMed ID: 15255075
[TBL] [Abstract][Full Text] [Related]
52. Membrane-bound carbonic anhydrases in osteoclasts.
Riihonen R; Supuran CT; Parkkila S; Pastorekova S; Väänänen HK; Laitala-Leinonen T
Bone; 2007 Apr; 40(4):1021-31. PubMed ID: 17291844
[TBL] [Abstract][Full Text] [Related]
53. In vitro generation of mature human osteoclasts.
Hemingway F; Cheng X; Knowles HJ; Estrada FM; Gordon S; Athanasou NA
Calcif Tissue Int; 2011 Nov; 89(5):389-95. PubMed ID: 21960377
[TBL] [Abstract][Full Text] [Related]
54. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption.
Sunyer T; Rothe L; Kirsch D; Jiang X; Anderson F; Osdoby P; Collin-Osdoby P
Endocrinology; 1997 May; 138(5):2148-62. PubMed ID: 9112415
[TBL] [Abstract][Full Text] [Related]
55. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass.
Masuyama R; Mizuno A; Komori H; Kajiya H; Uekawa A; Kitaura H; Okabe K; Ohyama K; Komori T
J Bone Miner Res; 2012 Aug; 27(8):1708-21. PubMed ID: 22492541
[TBL] [Abstract][Full Text] [Related]
56. [Hormonal regulation of bone metabolism].
Gera I
Fogorv Sz; 1993 Apr; 86(4):107-20. PubMed ID: 8243730
[TBL] [Abstract][Full Text] [Related]
57. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
[TBL] [Abstract][Full Text] [Related]
58. Calcitonin-derived peptide carriers: mechanisms and application.
Rennert R; Neundorf I; Beck-Sickinger AG
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173
[TBL] [Abstract][Full Text] [Related]
59. Urocortin is a novel regulator of osteoclast differentiation and function through inhibition of a canonical transient receptor potential 1-like cation channel.
Combs CE; Fuller K; Kumar H; Albert AP; Pirianov G; McCormick J; Locke IC; Chambers TJ; Lawrence KM
J Endocrinol; 2012 Feb; 212(2):187-97. PubMed ID: 22083217
[TBL] [Abstract][Full Text] [Related]
60. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
